OSSUY OTC
Embla Medical hf.
1W: +0.0%
1M: +0.0%
3M: +8.6%
YTD: -23.0%
1Y: +3.8%
3Y: +14.3%
5Y: -43.1%
$4.15
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$137M
+18.2% ▲
5Y CAGR: +8.3%
Capital Expenditures
$22M
+18.1% ▲
5Y CAGR: -1.6%
Free Cash Flow
$115M
+29.2% ▲
5Y CAGR: +11.0%
Dividends Paid
$0
+0.0% ▲
Buybacks
$10M
+0.0% ▲
Net Change in Cash
$16M
+20.4% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $64M | $43M | $58M | $68M | $84M |
| Depreciation & Amort. | $52M | $49M | $50M | $56M | $61M |
| Stock-Based Comp. | $2M | $2M | $2M | $0 | $0 |
| Change in Working Capital | -$21M | -$22M | -$13M | -$9M | -$8M |
| Other Non-Cash Items | $6M | -$9M | -$2M | $544K | $883K |
| Operating Cash Flow | $101M | $61M | $94M | $116M | $137M |
| — Investing Activities — | |||||
| Capital Expenditures | -$27M | -$26M | -$42M | -$39M | -$32M |
| Acquisitions (Net) | -$34M | -$42M | -$12M | -$80M | -$20M |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $1M | $1M | -$3M | $5M | -$3M |
| Investing Cash Flow | -$59M | -$66M | -$57M | -$114M | -$56M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$30M | $36M | -$15M | $40M | -$32M |
| Stock Repurchased | $0 | -$10M | $0 | $0 | -$10M |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$21M | -$22M | -$26M | -$24M | -$28M |
| Financing Cash Flow | -$51M | $4M | -$41M | $15M | -$70M |
| Net Change in Cash | -$17M | -$9M | -$4M | $14M | $16M |
| Cash End of Period | $85M | $77M | $73M | $86M | $103M |
| Free Cash Flow | $74M | $35M | $52M | $89M | $115M |